Results Timeline
Weeks 1-4:
- Significant visible changes typically do not occur during initial periods
- GH and IGF-1 levels elevate internally
- Some individuals report improved sleep quality, increased energy, and enhanced exercise recovery
Weeks 4-8:
- Subtle body composition improvements become noticeable, including mild abdominal bloating reduction
- Improved skin quality
- Laboratory testing typically shows elevated IGF-1 levels
Weeks 8-16:
- More pronounced visceral fat reductions become apparent
- Clinical trials demonstrated statistically significant visceral adipose tissue reduction by weeks 12-16
- Users often report improved muscle definition, particularly in abdominal regions
Weeks 16-26:
- Continued progressive improvement in body composition
- The pivotal Phase III trials showed approximately 15-18% reduction in visceral adipose tissue (measured by CT scan) at 26 weeks
- Lipid profile improvements, including reduced triglycerides, typically become measurable
Beyond 26 Weeks:
- Extended treatment continues maintaining or further improving results
- The 52-week extension studies demonstrated sustained benefits with continued use